Abstract Background Randomized controlled trials and real-world studies suggest that combination therapy with sodiumglucose transport protein 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) is associated with improvement in fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), systolic blood pressure (SBP), body mass index (BMI), and total cholesterol levels
It represents a potentially serious condition that requires prompt recognition and management
Antioxidant activity and protective effect of extract of Celosia cristata L
CRH stimulates ACTH synthesis and release into the bloodstream in the anterior pituitary gland, while AVP is released directly into the portal veins of the posterior pituitary ( Figure 1 )
Tamoxifen versus placebo in the treatment of Peyronie's disease
No interactions with other albumin-binding drugs have been shown (131, 132), likely because most other drugs do not bind to the fatty-acid binding sites